DASH — Disabilities of Arm, Shoulder and Hand Calculator

About

The DASH Outcome Measure was developed by the American Academy of Orthopaedic Surgeons (AAOS) in collaboration with the Institute for Work & Health (Toronto, Canada) and published in 1996. It is one of the most widely used patient-reported outcome measures for upper extremity conditions. The questionnaire asks patients to rate 30 items on a 5-point Likert scale from 1 (no difficulty) to 5 (unable to perform). Items cover daily activities, symptoms (pain, tingling, stiffness), social function, work function, sleep, and self-image. The score ranges from 0 (no disability) to 100 (most severe disability). The DASH has excellent psychometric properties with test-retest reliability of 0.96, construct validity demonstrated against the SF-36, and responsiveness to clinical change with a minimal clinically important difference (MCID) of approximately 10-15 points. The DASH is validated for a wide range of upper extremity conditions including rotator cuff disease, carpal tunnel syndrome, elbow arthritis, hand fractures, and following upper extremity surgery. A shorter 11-item version (QuickDASH) is also available. A 10-point change is considered the minimal clinically important difference.

Formula

DASH Score = ((Sum of 30 items / 30) - 1) × 25. Range: 0 (no disability) to 100 (severe disability).

The DASH score is calculated by summing all 30 item responses (each scored 1-5), dividing by 30 to get the mean item score, subtracting 1 (to shift the scale to 0-4), then multiplying by 25 to convert to a 0-100 scale. A score of 0 indicates no disability and 100 indicates the most severe disability. If more than 10% of items (3 items) are missing, the score should not be calculated. For missing items, the mean of the completed items can be substituted as per DASH scoring guidelines. The DASH should be interpreted as: 0-24 mild disability, 25-49 moderate disability, 50-74 severe disability, and 75-100 very severe disability. The minimal clinically important difference (MCID) is approximately 10-15 points, meaning a change of at least 10 points is needed to be considered clinically meaningful.

Score Interpretation

The DASH Outcome Measure is one of the most widely validated patient-reported outcome measures for upper extremity conditions. Its clinical significance derives from several key strengths. First, it provides a comprehensive assessment of the upper limb as a single functional unit rather than focusing on individual joints (shoulder, elbow, wrist, hand), reflecting the integrated nature of upper extremity function. Second, the DASH captures both physical function and symptoms including pain, tingling, weakness, and stiffness, providing a multidimensional assessment. Third, the DASH has been validated across a broad spectrum of upper extremity conditions including rotator cuff disease (MCID 10.2), lateral epicondylitis (MCID 11.5), carpal tunnel syndrome (MCID 10.7), hand and wrist fractures (MCID 12.0), and elbow arthritis (MCID 10.4). Fourth, the DASH is responsive to clinical change and is recommended by multiple specialty societies as the preferred outcome measure for upper extremity research. Fifth, population norms are available from general population studies allowing comparison of patient scores to age- and sex-matched controls. The DASH is recommended by the American Academy of Orthopaedic Surgeons (AAOS), the American Society for Surgery of the Hand (ASSH), and the International Consortium for Health Outcomes Measurement (ICHOM) for upper extremity conditions. The minimal clinically important difference (MCID) varies by condition but is generally accepted as 10-15 points. The minimal detectable change (MDC at 90% confidence) is approximately 12.7 points.

Reference Ranges